PT Kardia Indonesia Welcomes KV Asia Capital to Accelerate Its Next Phase of Growth
Jakarta, March 26th, 2026 – PT Kardia Indonesia (“Kardia Indonesia”), a leading specialist healthcare provider focused on cardiovascular services in Indonesia, today announced a strategic partnership with KV Asia Capital, a Southeast Asia-focused private equity firm. The collaboration reflects a shared commitment to expanding access to quality cardiovascular care and supporting the continued development of specialty healthcare services in Indonesia.
Through this partnership, Kardia Indonesia aims to further strengthen its integrated cardiovascular care platform while advancing its long-term vision of broadening access to quality medical treatment across the country. The collaboration will support Kardia Indonesia’s continued institutional development, operational excellence, and expansion into complementary specialty care services.
“Cardiovascular disease remains one of the leading health challenges in Indonesia, and expanding access to high-quality specialist care is central to our mission. We are pleased to partner with KV Asia Capital as we strengthen our clinical capabilities, enhance operational excellence, and expand the reach of our integrated platform to serve more patients across the country,” said Dr Fathema Djan, Co-Founder and President Commissioner of Kardia Indonesia.
Kardia Indonesia has established itself as one of Indonesia’s leading cardiovascular specialty providers, operating two heart hospitals and one multispecialty clinic. Founded and led by distinguished cardiac specialists: Dr Jusuf Rachmat, Dr Fathema Djan and Dr Ismail Dilawar, the organization combines deep clinical expertise with strong hospital management capabilities to deliver outstanding patient-centered care.
Building on its strong foundation, Kardia Indonesia is currently expanding its healthcare platform through several strategic expansion of multiple facilities for advanced diagnostic and oncology, further strengthening its position as an integrated center of excellence for critical and high-complexity medical services.
“This collaboration represents an important milestone in Kardia Indonesia’s development. With the support and regional perspective that KV Asia Capital brings, we are well positioned to accelerate the next phase of our growth while remaining focused on what matters most—delivering high-quality, patient-focused healthcare,” added dr. Andi Yassin, President Director of Kardia Indonesia.
KV Asia Capital brings extensive regional experience working alongside entrepreneurs and management teams across Southeast Asia. The firm focuses on supporting companies with strong fundamentals and long-term growth potential across Singapore, Malaysia, Indonesia, Vietnam, the Philippines and Thailand.
“Indonesia is a key market for KV Asia Capital, and we see strong long-term potential as the country continues to strengthen its healthcare ecosystem. Kardia Indonesia stands out for its clinical leadership and well-established specialty care platform, and we are pleased to work alongside the team as they expand access to advanced specialized healthcare services,” said Vibhav Panandiker, the Co-Founder and Partner of KV Asia Capital.
“As Indonesia’s healthcare needs continue to evolve, the role of focused specialty providers will become increasingly important. Kardia Indonesia is a one-of-a-kind institution that plays an important role in elevating the homegrown quality of cardiovascular care as well as the advancing the development of broader multispecialty treatment capabilities in the country,” Yansen Poaler, Director of KV Asia Capital added.
The partnership reflects a shared vision to build on Kardia Indonesia’s strong foundation and reputation in cardiovascular care while continuing to develop capabilities that address Indonesia’s growing healthcare needs in other specialty fields.
About PT Kardia Indonesia
PT Kardia Indonesia is a leading cardiology healthcare provider offering integrated cardiovascular services through two heart hospitals and one multispecialty clinic. Founded and led by distinguished cardiac specialists, the company combines deep clinical expertise with strong hospital management capabilities to deliver high-quality, patient-centered care.
Expanding beyond its established platform, PT Kardia Indonesia is developing new facilities to enable advanced diagnostics and oncology services. PT Kardia Indonesia is also growing its footprint with new specialty hospitals focused on cardiovascular, oncology, and stroke care, further solidifying its role as a comprehensive provider of high-acuity medical services in Indonesia.
About KV Asia Capital
KV Asia Capital is a private equity fund focused on mid-market investments across Southeast Asia. Headquartered in Singapore with offices in Malaysia, Indonesia and Vietnam, the firm has a multi-year track record of successfully investing behind proven entrepreneurs and management teams and compelling business opportunities across a range of industries including consumer, education, healthcare, manufacturing and services.
With a strategy of driving improvements in investee companies via operational value-add and ESG initiatives as well as dedicated strategy and execution support, KV Asia Capital works towards developing market leaders and driving profitable growth across Southeast Asia.